Sanchez, Bb Boy .
HRN: 26-80-41 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/12/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/12/2025
03/19/2025
IV
28mg
OD
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes